CHTH CNL Healthcare Pptys Inc. Forecast, Technical & Fundamental Analysis

CHTH's Stochastic Oscillator slumps into oversold zone

The Stochastic Oscillator for CHTH moved into oversold territory on January 14, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CHTH just turned positive on December 29, 2025. Looking at past instances where CHTH's MACD turned positive, the stock continued to rise in of 34 cases over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 24 cases where CHTH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.902) is normal, around the industry mean (2.170). P/E Ratio (0.000) is within average values for comparable stocks, (67.400). CHTH's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.540). CHTH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.062). CHTH's P/S Ratio (1.652) is slightly lower than the industry average of (7.001).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock worse than average.